• 1. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

• Other Chemical Reagents

Introduction to 4-Chloro-2-ethoxyphenylboronic Acid (CAS No. 850568-80-8)

4-Chloro-2-ethoxyphenylboronic acid is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science due to its versatile applications. This compound, identified by the Chemical Abstracts Service Number (CAS No.) 850568-80-8, features a unique structural motif comprising a chloro-substituted phenyl ring linked to an ethoxy group, with a boronic acid functional group at the 2-position. The presence of these functional groups imparts distinct chemical reactivity, making it a valuable intermediate in organic synthesis and a potential candidate for drug discovery initiatives.

The 4-chloro-2-ethoxyphenylboronic acid structure is particularly noteworthy for its role in cross-coupling reactions, which are fundamental to modern synthetic chemistry. Boronic acids are well-known for their ability to participate in Suzuki-Miyaura coupling reactions, a palladium-catalyzed process that facilitates the formation of carbon-carbon bonds between aryl or vinyl boronic acids and halogenated aromatic compounds. This reaction is widely employed in the construction of complex molecular architectures, including those relevant to medicinal chemistry.

In recent years, the pharmaceutical industry has increasingly leveraged boronic acid derivatives for their potential therapeutic applications. The 4-chloro-2-ethoxyphenylboronic acid derivative, with its chloro and ethoxy substituents, offers a balance of reactivity and stability that makes it suitable for various synthetic pathways. For instance, researchers have explored its utility in generating novel heterocyclic compounds, which are often found in biologically active molecules. The chloro group can be further functionalized through nucleophilic aromatic substitution or metal-catalyzed coupling reactions, expanding the compound's synthetic utility.

One of the most compelling aspects of 4-chloro-2-ethoxyphenylboronic acid is its application in the development of targeted drug therapies. Boron-containing compounds have been investigated for their potential in both diagnostics and therapeutics. For example, boron neutron capture therapy (BNCT) relies on specific boron carriers to target cancer cells selectively. While 4-chloro-2-ethoxyphenylboronic acid itself may not be directly used as a therapeutic agent, its derivatives have been explored as precursors to more complex boronated molecules designed to enhance drug delivery and efficacy.

The Suzuki-Miyaura coupling reaction involving 4-chloro-2-ethoxyphenylboronic acid has been particularly studied in the context of developing small-molecule inhibitors. These inhibitors are critical tools in drug discovery, allowing researchers to probe the mechanisms of various biological pathways. By incorporating this boronic acid into larger molecular frameworks, scientists can create compounds that modulate enzyme activity or interfere with protein-protein interactions. Such modulators have shown promise in treating conditions ranging from inflammatory diseases to infectious disorders.

Advances in computational chemistry have further enhanced the utility of 4-chloro-2-ethoxyphenylboronic acid. Molecular modeling studies can predict how this compound interacts with biological targets, providing insights into its potential pharmacological effects. Additionally, computational methods can guide the design of optimized derivatives with improved properties such as enhanced solubility or selectivity. This interdisciplinary approach underscores the importance of integrating synthetic chemistry with computational biology to accelerate drug development.

In materials science, 4-chloro-2-ethoxyphenylboronic acid has found applications in the synthesis of advanced polymers and coatings. The ability to incorporate boronic acid functionalities into polymer backbones can lead to materials with unique properties, such as responsiveness to environmental stimuli or enhanced biodegradability. These innovations highlight the broad utility of organoboron compounds beyond traditional pharmaceutical applications.

The synthesis of 4-chloro-2-ethoxyphenylboronic acid itself is an area of active research. Recent methodologies have focused on improving yields and reducing costs through greener synthetic routes. For instance, catalytic processes that minimize waste or employ renewable feedstocks are being developed alongside traditional multi-step syntheses. Such efforts align with broader trends in sustainable chemistry aimed at reducing the environmental impact of chemical production.

Future directions for research on 4-chloro-2-ethoxyphenylboronic acid may include exploring its role in photopharmacology—where light-sensitive drugs are designed to release active molecules upon irradiation. The compound's boronic acid moiety could serve as a photoswitching platform, enabling controlled drug release mechanisms that could improve therapeutic outcomes.

In conclusion, 4-chloro-2-ethoxyphenylboronic acid (CAS No. 850568-80-8) represents a fascinating compound with far-reaching implications across multiple scientific disciplines. Its unique structural features make it indispensable in synthetic organic chemistry, particularly for constructing complex molecular architectures relevant to drug discovery and materials science. As research continues to uncover new applications and synthetic strategies for this compound, its importance is likely to grow further.

• 89694-48-4((5-chloro-2-methoxyphenyl)boronic acid)
• 762287-57-0((4-chloro-2-methoxyphenyl)boronic acid)
• 352534-87-3([5-chloro-2-(propan-2-yloxy)phenyl]boronic acid)
• 352534-88-4((2-Butoxy-5-chlorophenyl)boronic acid)
• 313545-44-7(2-chloro-4-ethoxypheylboronic acid)
• 849062-29-9((5-Chloro-2-propoxyphenyl)boronic acid)
• 352534-86-2(5-Chloro-2-ethoxyphenylboronic acid)
• 936249-26-2(Boronic acid,B-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-)
• 385370-80-9((2-chloro-6-methoxyphenyl)boronic acid)
• 213211-69-9(2-Ethoxyphenylboronic acid)